+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cardiac POC Testing Devices Market 2019-2023 - Product Image

Global Cardiac POC Testing Devices Market 2019-2023

  • ID: 4825194
  • Report
  • Region: Global
  • 126 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMérieux SA
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Siemens Healthcare GmbH.
  • MORE
Global Cardiac POC Testing Devices Market: About this market

Cardiac POC testing devices aid in the assessment of glucose and cholesterol levels in individuals, which in turn help the practitioners to identify the risk of developing thrombosis and cardiovascular diseases (CVDs) such as coronary artery disease (CAD), myocardial infarction and heart failure. The cardiac POC testing devices market analysis considers sales from hospitals and laboratories, diagnostic centers, and ambulatory centers and physicians' clinics. Our analysis also considers the sales of cardiac POC testing devices in Asia, Europe, North America, and ROW. In 2018, the hospitals and laboratories segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as High inflow of patients, expanding the use of medical devices, and growing healthcare expenditure will play a significant role in the hospitals and laboratories segment to maintain its market position. Also, our global cardiac POC testing devices market report also looks at factors such as high incidence of CVDs, growing diabetic population, emphasis on cardiac marker testing regulatory authorities. However, product recalls posing a challenge to manufacturers, alternative methods of measuring cholesterol levels, limited access to diagnostic tests in developing countries may hamper the growth of the cardiac POC testing devices industry over the forecast period.

Global Cardiac POC Testing Devices Market: Overview

High incidence of CVDs

Cardiovascular diseases (CVDs) are rising due to a high level of a sedentary lifestyle, smoking, alcohol consumption, high levels of cholesterol in the blood, and diabetes, and others. This has driven the demand for cardiac POC testing devices. Elevated cholesterol levels shoot up the blood pressure. Cardiac POC testing devices’ ability to assess blood glucose and cholesterol levels rapidly has also increased its adoption rate. This demand will lead to the expansion of the global cardiac POC testing devices market at a CAGR of over 6% during the forecast period.

Technological advances in diagnostics

The global cardiac POC testing devices market has witnessed significant developments, owing to factors such as portability of devices, research centers moving to close patent locales, increasing test menus, and rising adoption of multiparameter monitoring devices. The implementation of laboratory functions into portable systems has led to a standard shift in the diagnostics field. Miniaturization of technology aids in the quantification of living cells on portable systems using small volumes of reagents. This has encouraged several hospitals and clinics across the world to switch from conventional testing methods to POC testing due to its improved efficiency and faster turnaround time. Sensors, microsystems, and low-cost imaging technologies have been developed for POC testing. This development is expected to have a positive impact on the overall market growth.

Competitive Landscape

With the presence of a few major players, the global cardiac POC testing devices market is moderately concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiac POC testing devices manufacturers, that include Abbott Laboratories, bioMérieux SA, Danaher Corp., F. Hoffmann La Roche Ltd., and Siemens Healthcare GmbH.

Also, the cardiac POC testing devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMérieux SA
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Siemens Healthcare GmbH.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY END-USER
  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals and laboratories - Market size and forecast 2018-2023
  • Diagnostic centers - Market size and forecast 2018-2023
  • Ambulatory centers and physicians' clinics - Market size and forecast 2018-2023
  • Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Increasing online presence of vendors
  • Technological advances in diagnostics
  • Advent of wearable devices
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMérieux SA
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Siemens Healthcare GmbH
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits:
Exhibit 01: Product overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: End-user - Market share 2018-2023 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Hospitals and laboratories - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Hospitals and laboratories - Year-over-year growth 2019-2023 (%)
Exhibit 22: Diagnostic centers - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Diagnostic centers - Year-over-year growth 2019-2023 (%)
Exhibit 24: Ambulatory centers and physicians' clinics - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Ambulatory centers and physicians' clinics - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by end-user
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America - Year-over-year growth 2019-2023 (%)
Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abbott Laboratories - Vendor overview
Exhibit 47: Abbott Laboratories - Business segments
Exhibit 48: Abbott Laboratories - Organizational developments
Exhibit 49: Abbott Laboratories - Geographic focus
Exhibit 50: Abbott Laboratories - Segment focus
Exhibit 51: Abbott Laboratories - Key offerings
Exhibit 52: bioMérieux SA - Vendor overview
Exhibit 53: bioMérieux SA - Product segments
Exhibit 54: bioMérieux SA - Organizational developments
Exhibit 55: bioMérieux SA - Geographic focus
Exhibit 56: bioMérieux SA - Key offerings
Exhibit 57: Danaher Corp. - Vendor overview
Exhibit 58: Danaher Corp. - Business segments
Exhibit 59: Danaher Corp. - Organizational developments
Exhibit 60: Danaher Corp. - Geographic focus
Exhibit 61: Danaher Corp. - Segment focus
Exhibit 62: Danaher Corp. - Key offerings
Exhibit 63: F. Hoffmann La Roche Ltd. - Vendor overview
Exhibit 64: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 65: F. Hoffmann La Roche Ltd. - Organizational developments
Exhibit 66: F. Hoffmann La Roche Ltd. - Geographic focus
Exhibit 67: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 68: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 69: Siemens Healthcare GmbH - Vendor overview
Exhibit 70: Siemens Healthcare GmbH - Business segments
Exhibit 71: Siemens Healthcare GmbH - Organizational developments
Exhibit 72: Siemens Healthcare GmbH - Geographic focus
Exhibit 73: Siemens Healthcare GmbH - Segment focus
Exhibit 74: Siemens Healthcare GmbH - Key offerings
Exhibit 75: Validation techniques employed for market sizing
Exhibit 76: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMérieux SA
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Siemens Healthcare GmbH.
  • MORE
The following companies are recognised as the key players in the global cardiac POC testing devices market: Abbott Laboratories, bioMérieux SA, Danaher Corp., F. Hoffmann La Roche Ltd., and Siemens Healthcare GmbH.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances in diagnostics.”

According to the report, one of the major drivers for this market is the high incidence of CVDs.

Further, the report states that one of the major factors hindering the growth of this market is the limited access to diagnostic tests in developing countries.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott Laboratories
  • bioMérieux SA
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Siemens Healthcare GmbH.
Note: Product cover images may vary from those shown
Adroll
adroll